Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxycodone hydrochloride
Drug ID BADD_D01646
Description Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917.[A178696] It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label] The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.[L6460]
Indications and Usage Oxycodone is indicated for the treatment of moderate to severe pain.[Label] There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label]
Marketing Status approved; illicit; investigational
ATC Code N02AA05
DrugBank ID DB00497
KEGG ID D00847
MeSH ID D010098
PubChem ID 5462350
TTD Drug ID D07WPQ
NDC Product Code 31722-918; 0115-1560; 42806-008; 42858-001; 43386-433; 43386-434; 50383-961; 57664-187; 63629-1930; 63629-4606; 63629-7399; 63629-8889; 66689-403; 70752-137; 71335-0115; 72162-1749; 81140-103; 0904-6828; 10702-056; 10702-057; 13107-055; 0093-5731; 31722-917; 0121-4839; 42806-007; 57664-224; 59011-430; 0406-8557; 68094-801; 68462-347; 69344-113; 0054-0390; 71930-023; 61960-9143; 10702-008; 17856-0023; 0115-1562; 0121-0826; 42858-004; 42858-010; 47781-263; 55700-174; 57664-371; 59011-420; 59011-460; 62559-151; 63629-1927; 63629-2104; 69344-213; 70752-136; 71335-1421; 71335-1422; 72162-1334; 60432-706; 63629-8526; 66689-025; 67296-1595; 0406-8520; 68071-2536; 68308-145; 71335-1245; 71335-9606; 0792-2936; 38779-0725; 69988-0034; 0121-4827; 42858-005; 43386-920; 55700-509; 57664-370; 62559-167; 67296-1560; 0406-0552; 0406-8510; 71335-1414; 72162-1336; 72189-094; 72865-129; 0904-6678; 10702-018; 10702-023; 13107-057; 0115-1556; 0121-0827; 42806-006; 47781-264; 63629-1174; 67296-1324; 0406-8515; 0406-8530; 68071-2899; 68084-983; 68462-204; 71335-1413; 71930-022; 72162-1335; 81140-101; 10702-009; 0093-5733; 0093-5734; 23635-582; 0115-1561; 42858-003; 59011-415; 59011-440; 63629-1928; 64950-354; 66689-401; 67296-1376; 0406-8556; 71335-1361; 72865-128; 81140-102; 51927-1008; 17856-0390; 0115-1557; 0115-1559; 43386-431; 59011-410; 63629-1929; 63629-8890; 64950-353; 64950-901; 67296-1040; 67296-1434; 68084-354; 68308-020; 43386-430; 68084-968; 68084-975; 68094-005; 71335-2126; 72189-095; 49452-0034; 10702-183; 13107-056; 0093-5732; 0115-1558; 42806-009; 42858-002; 47781-265; 57664-223; 60687-406; 63629-3775; 0527-1774; 72162-1337; 51634-0002; 10702-171; 67509-006; 23635-581; 42806-005; 43386-432; 50383-964; 59011-480
UNII C1ENJ2TE6C
Synonyms Oxycodone | Dihydrone | Oxycone | Dihydrohydroxycodeinone | Oxycodeinon | Eucodal | Theocodin | Oxycodone Hydrochloride | Oxycontin | Pancodine | Dinarkon | Oxiconum
Chemical Information
Molecular Formula C18H22ClNO4
CAS Registry Number 124-90-3
SMILES CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tinnitus04.04.01.002; 17.04.07.004--
Tremor17.01.06.002--
Urinary retention20.02.02.011--
Urinary tract infection11.01.14.004; 20.08.02.001--
Urticaria10.01.06.001; 23.04.02.001--
Vertigo04.04.01.003; 17.02.12.002--
Visual impairment06.02.10.013---
Vomiting07.01.07.003--
Withdrawal syndrome08.06.02.012; 19.07.06.023---
Morbid thoughts19.10.03.004---
Deep vein thrombosis24.01.02.003---
Inappropriate antidiuretic hormone secretion05.03.03.001; 14.05.07.001---
Affect lability19.04.01.001---
Haemorrhage24.07.01.002---
Vasodilation procedure25.03.01.001---
Hepatic enzyme increased13.03.04.028---
Decreased appetite08.01.09.028; 14.03.01.005--
Erectile dysfunction19.08.04.001; 21.03.01.007--
Cardiovascular insufficiency02.11.01.011; 24.06.03.005---
Substance abuse19.07.06.018---
Regurgitation07.01.07.004---
Foreign body12.01.08.018---
Depersonalisation/derealisation disorder19.14.01.004---
The 5th Page    First    Pre   5    Total 5 Pages